« Return to News | CROs/Service Providers

eClinical Market Has Strong Year

Monday, November 27, 2006 10:01 AM

In its third quarter, Morrisville, N.C.-based eClinical service provider etrials reported 40% growth in services revenue to $4.4 million.Net revenues during the same period in 2005 were $3.2 million. The company reported operating income of $178,331 compared with an operating loss of $148,618 in 2005 during the same period. etrials went public in 2005 in a reverse merger.

Major players in the eClinical market have seen high revenue growth in 2006, primarily due to an increase in EDC adoption and a less fragmented industry. Medidata Solutions reported the company’s 22nd quarter of consecutive growth. Medidata had a 189% increase in year-over-year revenue in the second quarter of 2006, and a 171% increase in year-over-year revenue for the first half.

United Kingdom-based ClinPhone released interim financial results for its six months ending Aug. 31. ClinPhone reported its revenue increased 32% to £20.7 million ($39.5 million) compared with £15.6 ($29.7 million) during the same period of 2005.One notable exception was eResearch Technology, which reported lower than expected earnings in its third quarter. The company’s share price dropped 22% to $6.04 on Nov. 9.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.